KRAS and infantile convulsions and choreoathetosis: In the same study, the authors developed a novel KRAS-driven murine model of iCCA to further explore the mechanisms of tumorigenesis and evaluate the therapeutic efficacy of targeting the ERK1/2 signaling pathway.